StopAfib.org is excited to announce our participation in FacingAFib, partnering with daytime TV star Susan Lucci, her husband Helmut Huber, Boehringer Ingelheim Pharmaceuticals, Inc., and the National Stroke Association. FacingAFib (www.FacingAFib.com) is a new national education program to improve awareness of Afib and its increased risk of stroke. To learn more, see: TV Star Susan …
Read MoreArchives
An FDA panel today unanimously recommended that the FDA approve dabigatran (Pradaxa) for reducing the risk of afib strokes. FDA approval is expected quickly, making this the first alternative to warfarin approved in the United States, and also the first atrial fibrillation approval for dabigatran. It is approved in over 70 countries for venous thromboembolisms …
Read MoreNext Monday, September 20, 2010, StopAfib.org will be covering the FDA's hearing on dabigatran (Pradaxa), the new alternative to warfarin, and will be "live-tweeting" from the hearing. Get first reports as they happen by following @stopafib on Twitter. If you're already on Twitter, just follow us from the toolbar at the bottom of this page. …
Read MoreStopAfib.org interviews Dr. Peter Kowey See the full transcript at: www.stopafib.org In this video interview at Boston Atrial Fibrillation Symposium 2010, Dr. Peter Kowey talked about a number of exciting new things in the atrial fibrillation world, including the Cabana clinical trials, the Safari catheter ablation registry, dronedarone as a …
Read MoreNot all atrial fibrillation patients are candidates for an ablation, either catheter ablation or surgical ablation, such as the maze or mini maze procedures. Thus their stroke risk remains high. We recently wrote about the FDA’s approval of the AtriClip device, which is implanted during open heart surgery and reduces stroke risk by occluding (closing …
Read MoreAF patients are generally at a higher risk for stroke and thus may have to take anticoagulant medications, such as Coumadin or warfarin, to manage their afib-related stroke risk. With the FDA's recent approval of AtriCure's AtriClip device that is implanted during open heart surgery, afib patients and their doctors may now have another way …
Read MoreStopAfib.org is joining with the Arrhythmia Alliance (A-A), ICPES (International Cardiac Pacing and Electrophysiology), and numerous other international organizations in celebrating World Heart Rhythm Week. This annual global event is focused on raising awareness of, and education about, heart rhythm disorders such as atrial fibrillation and other heart arrhythmias. StopAfib.org is proud to be a …
Read MoreIn this video interview, Dr. Nassir Marrouche talked about the exciting research he and his team presented at Heart Rhythm 2010 that allows them to personalize atrial fibrillation (AF) treatment. They do catheter ablations and manage stroke prevention based on the amount of atrial fibrosis and atrial remodeling detected by …
Read MoreCardiothoracic surgeon Dr. James Edgerton of The Heart Hospital Baylor Plano (Plano, TX) spoke at an evening presentation at the Boston Atrial Fibrillation Symposium 2009 about the evolution and future of surgical procedures for atrial fibrillation. A full video transcript can be found at: stopafib.org
Read MoreCardiothoracic surgeon Dr. James Edgerton of The Heart Hospital Baylor Plano (Plano, TX) spoke at an evening presentation at the Boston Atrial Fibrillation Symposium 2009 about the evolution and future of surgical procedures for atrial fibrillation. A full video transcript can be found at: stopafib.org
Read More